Company Overview and News
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Piedmont Lithium Limited (“Piedmont” or “Company”) (ASX:PLL) (NASDAQ:PLLL) is pleased to report the results of the Company’s Scoping Study for its vertically-integrated Piedmont Lithium Project (“Project”) located within the Carolina Tin-Spodumene Belt in North Carolina, USA (“TSB”). The Project includes a lithium hydroxide chemical plant (“Chemical Plant”) supplied with spodumene concentrate from an open pit mine and concentrator (“Mine/Concentrator”).
PDDTF PLLL LTUM ALB FTI.WI FMC
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Piedmont Lithium Limited (“Piedmont” or “Company”) (ASX:PLL) (NASDAQ:PLLL) is pleased to report that the Company has completed a bench-scale metallurgical testwork program to produce spodumene concentrate from ore samples from the Company’s proposed vertically-integrated Piedmont Lithium Project located in North Carolina, USA. Piedmont has partnered with North Carolina State University’s Minerals Research Laboratory (MRL) to complete bench-scale testwork including spodumene flotation optimization, magnetic separation to remove iron from spodumene concentrate and Heavy Liquid Separation (HLS) to evaluate the potential for a Dense Medium Separation (DMS) circuit.
PDDTF PLLL LTUM ALB FTI.WI FMC
Domtar Corporation (UFS - Free Report) recently acquired a majority interest in Prisma Renewable Composites, LLC. This investment will help boost the process of commercializing Domtar’s lignin-based applications. Prisma Renewable Composites is a Knoxville-based spin-off of TennEra, LLC, which is primarily involved in the development of advanced materials from lignin and other natural resources. Per the investment, Domtar will employ Prisma's scientific research capabilities and unique product development strategy, alongwith its commercialization and lignin production expertise.
UPMKY KMG FTI.WI UFS FMC CE
On Jul 10, we issued an updated research report on Vale S.A. (VALE - Free Report) . The company’s performance will be backed by rise in global steel production and strong cash generation. However, its results might be marred by rising cost of sales and unfavorable exchange rates. Let’s illustrate these factors in detail. Rise in Steel Production to Boost Top Line Vale's net operating revenues in first-quarter 2018 benefited from elevated sales prices of the Base Metals segment and sturdier sales volumes of the Ferrous Minerals segment.
UPMKY KMG FTI.WI FMC CE
The chemical industry is riding an upturn in the global economy and strength across major end-use markets such as construction and automotive. Improving fundamentals in the energy space driven by an upswing in crude oil prices also augur well for the industry. Notwithstanding a few headwinds, including a spike in raw materials costs and softness in agricultural commodity prices, chemical companies are expected to continue the earnings momentum witnessed in Q1 into Q2 as the fundamental driving factors remain in place.
PPG LYB FTI.WI FMC CE
United States Steel Corporation’s (X - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it is poised to carry the momentum ahead. Let’s take a look into the factors that make this steel giant a compelling choice for investors right now. What’s Working in Favor of X? Solid Rank & VGM Score: U.
X ABX WLK FTI.WI FMC CC ABX
This article was first published on Trend Investing on May 4; therefore all data is as of that date.
URA CLA CCZ SRHYY KBGCF CYDVF LMRMF PCRCF PLM.RT HNCKF SNNAF ZEYYF WML POR SQM AVLNF BXTMF AIS.H POM AYR KBBRF ABE FTMDF MNIKF GBLEF GLCNF TON NMKEF POS DNI MGXMF DJIFF GME CRECF AQR LMR NGPHF CDNMD LEMIF CDNMF GLK WWR AEOMF KATFF KNL NTTHF ECORF URI CNJ TSLA FCSMF HLPCF CUC AJM WSCRF GRXXF SIE TNTMF CXO SAV HAV LIACF MUM URLNF NI HIG URRE PFFOF TAKRF ABEPF PSDNF STLHF SYA GPHOF LLG APMFD WMLLF APMFF NSRC CYLYF NGZ RNX.WT GXY KAT PLU VNCKF AMLM CSSQF XTM AVL ALB FMS LACDF HBNRF CZI ZENYF AUZ RNX PLUUF RNKLF DMNKF NMX SYR GLKIF EMH OROCF MSMGD LAC MSMGF PLS FT CARCF FTI.WI FMC ZEN USCFF DJI SYAAF PDDTF PLM AVLIF CYP NSRCF MGPHF MCCBF LNZCF ORE AVZ
FMC Corporation (FMC - Free Report) has been performing well of late. The chemical company has seen its shares pop around 17% over the past three months, outperforming the industry’s 3.6% rise. The price performance has been backed by strong first-quarter results and the company’s upward guidance revision for the full year. With strong fundamentals and solid long-term growth prospects, this stock can be considered a solid bet now.
VSM.WI WLK FTI.WI FMC VSM CC
Steel Dynamics, Inc. (STLD - Free Report) has completed the previously announced acquisition of Heartland Steel Processing, LLC, formerly known as Companhia Siderurgica Nacional, LLC (Heartland), from CSN Steel, S.L.U., for $400 million in cash (including $60 million of normalized working capital), subject to customary transaction purchase price adjustments. The deal was funded with available cash with an expectation of near-term cash flow and earnings per share accretion.
STLD WLK FTI.WI FMC CC
LyondellBasell Industries N.V.'s (LYB - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s delve deeper into the factors that make this chemical giant an intriguing choice for investors right now. What Makes LYB an Attractive Pick? Solid Rank & VGM Score: LyondellBasell currently has a Zacks Rank #2 (Buy) and a VGM Score of A.
WLK LYB FTI.WI FMC CC
Steel Dynamics, Inc. (STLD - Free Report) recently announced plans to expand its value-added flat roll steel products by adding a new galvanizing line in Columbus, MS. It intends to invest roughly $140 million for adding a third galvanizing line at its Columbus Flat Roll Division. Construction is expected during the next 24 months while operations are likely to start mid-2020. After completion, the company will have nine value-added galvanizing lines with total annual coating capacity of roughly 3.
STLD WLK GM.WS.A GM.WS.B FTI.WI GM.WS.C FMC GM GM.WSB PII CC
On Jun 28, we issued an updated research report on Royal Gold, Inc. (RGLD - Free Report) . The company is poised to gain from improved production and progress in ramping up of new mines, as well as its debt-reduction efforts. However, inadequate water supplies at Mount Milligan and volatile gold prices are expected to affect its results. Let’s illustrate these growth factors in detail. Royal Gold to Gain From New Mines Royal Gold expects to start initial production from Peñasquito Pyrite Leach in LaRonde Zone 5 later in calendar year 2018, followed by Cortez Crossroads’ production.
FTI.WI FMC RGLD GM.WS.A KMG GM.WS.B GM.WS.C GM GM.WSB PII MEOH RGL
Dempsey Minerals Ltd (ASX:DMI) is riding the lithium wave with its primary focus on the prolific Lithium Triangle area of Argentina and shares reflect the strategy.
GXY GALXF FTI.WI FMC DMI SQM
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to FMC / FMC Corp. on message board site Silicon Investor.
|FMC Technologies||FMILX u0026amp; FMCSX are the best mutual funds|
|YFMC HEALTHCARE ( YFM )|
as of ET